Most microdosing protocols run four to eight weeks before a break, though there is no single clinically proven timeline. The most widely followed schedule, often called the Fadiman protocol, involves dosing once every three days for about a month, then pausing to assess how you feel. Beyond that initial cycle, the question of how long to continue gets more nuanced and depends on what you’re experiencing, how your body responds, and some real safety considerations around long-term use.
Common Protocols and Their Timelines
The most popular microdosing schedule calls for one dose every third day. The logic is straightforward: the dose itself affects you on day one, a residual effect may carry into day two, and day three serves as a baseline before the next dose. Most people following this pattern run it for four to six weeks, then take a reset period of two to four weeks before starting again.
A second well-known approach uses a four-days-on, three-days-off pattern each week, typically also run in cycles of about a month. In practice, though, people vary quite a bit. A six-week tracking study found that participants dosed about five times on average over that period, with a mean gap of nearly seven days between doses. That’s considerably less frequent than either protocol suggests, which hints at how much individual experimentation shapes real-world use.
A clinical trial testing microdoses for major depression used a once-weekly schedule for eight weeks total, split into a four-week experimental phase followed by four weeks of open-label dosing. That eight-week window, with follow-up extending a month beyond, gives a rough sense of the timeframes researchers consider reasonable for studying effects and safety.
When You Might Notice Changes
A 30-day study out of the University of British Columbia found that people who microdosed psilocybin mushrooms showed greater improvements in mood, depression, anxiety, stress levels, and psychomotor ability compared to non-microdosing peers over that one-month window. That suggests a month is a reasonable minimum commitment if you want to evaluate whether microdosing is doing anything meaningful for you.
That said, some people report noticing subtle shifts in mood or focus within the first week or two. The challenge is distinguishing genuine effects from expectation. Placebo effects in microdosing research are notoriously strong, so giving yourself a full cycle of four to six weeks, and honestly comparing dosing periods with off periods, gives you a more reliable picture.
Why Rest Days and Breaks Matter
Rest days aren’t optional padding in a protocol. They exist because of how your brain responds to repeated exposure. The receptors that psychedelics act on lose sensitivity quickly with repeated stimulation. Animal studies show that consistent dosing with similar compounds can reduce receptor activity by around 40% within just 24 hours of repeated exposure, and those receptors take roughly four to six days to fully recover. Dosing every day, or even every other day, likely blunts the very effects you’re after.
The longer breaks between cycles, typically two to four weeks, serve a different purpose. They let you observe your baseline without any influence from the substance. If the improvements you noticed during a dosing cycle persist into your break, that’s useful information. If everything reverts immediately, that tells you something too. These off periods also help you catch any subtle negative shifts, like creeping anxiety or sleep disruption, that might build so gradually during a cycle that you don’t notice them in real time.
The Case Against Indefinite Use
One of the most important reasons to limit microdosing duration involves your heart. Both LSD and psilocybin are structurally similar to several medications that have been pulled from the market or flagged for causing heart valve damage when taken regularly. These substances activate the same receptor on heart valve tissue that drugs like fenfluramine (the diet pill behind the fen-phen scandal) and certain migraine medications are known to overstimulate, leading to valve thickening and impaired function.
A 2024 review in the Journal of Psychopharmacology evaluated this risk and concluded that heart valve disease is a potential concern of long-term microdosing that should be taken seriously. The damage, called valvulopathy, involves progressive thickening of heart valves that can lead to regurgitation, arrhythmias, or in severe cases heart failure. Once established, this kind of fibrosis is difficult to reverse. The risk appears to scale with how frequently you dose and for how long, which is precisely why open-ended, months-long or years-long microdosing without breaks raises concern even though no human cases linked specifically to microdosing have been documented yet.
This doesn’t mean a single four-week cycle poses a clear cardiac risk. But it does mean that treating microdosing as a daily supplement you take indefinitely, the way some online communities frame it, ignores a plausible and serious long-term hazard.
Signs a Cycle Should End Early
Not every microdosing cycle needs to run its full course. Increased anxiety is one of the more commonly reported negative effects, and if it shows up consistently on dosing days or builds over the first couple of weeks, that’s a signal to stop rather than push through. Physical discomfort, particularly persistent headaches, nausea, or digestive issues, is another reason to cut a cycle short. Some people also report impaired focus, the opposite of what they were hoping for, which tends to show up as mental restlessness or difficulty sustaining attention on tasks that were previously manageable.
Sleep disruption is worth watching closely. If you’re waking more frequently, sleeping lighter, or finding it harder to fall asleep on dosing days, adjusting timing or dose may help, but if it persists, ending the cycle early is reasonable. Any noticeable mood instability, such as increased irritability, emotional flatness, or mood swings that weren’t present before, also warrants stopping.
A Practical Framework
If you’re starting out, a single cycle of four to six weeks using an every-third-day schedule gives you enough data points to evaluate your response. Typical microdoses fall in the range of 0.2 to 0.5 grams of dried psilocybin mushrooms or 10 to 20 micrograms of LSD. These amounts should remain below the threshold of any noticeable psychoactive effect. If you’re feeling perceptibly altered, the dose is too high.
After your first cycle, take at least two to four weeks completely off. Use that time to compare your baseline against how you felt during the dosing period. If you decide to run another cycle, keep the same structure. Many practitioners suggest capping total microdosing at two or three cycles before taking a longer break of a few months, though this recommendation comes from community experience rather than clinical evidence.
Keeping a simple daily journal, even just a few words about mood, energy, sleep quality, and focus, makes it far easier to spot both benefits and problems that would otherwise blur together over weeks. The goal isn’t to microdose forever. It’s to run a deliberate, time-limited experiment with clear start and end points, evaluate honestly, and make your next decision based on what you actually observed.